Clinical Trial Update: Comparison of HYDROLINK™ and HeprAN™ mEmbranes in a Per Dialytic Heparin Weaning Strategy in Chronic Hemodialysis Patients [NA]

View source ↗

Summary

A clinical trial evaluating HYDROLINK™ versus HeprAN™ dialysis membranes in a per-dialysis heparin-weaning strategy for patients with renal insufficiency underg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• HYDROLINK™ membrane
• HeprAN™ membrane

Snippet

Sponsor: CHU de Reims | Conditions: Renal Insufficiency | NA | Status: RECRUITING